OPTI vs. CYAN, OKYO, REVB, PHE, IGAS, CRDL, ALT, IDP, BON, and JAN
Should you be buying OptiBiotix Health stock or one of its competitors? The main competitors of OptiBiotix Health include CyanConnode (CYAN), OKYO Pharma (OKYO), Revolution Beauty Group (REVB), PowerHouse Energy Group (PHE), IGas Energy (IGAS), Cordel Group (CRDL), Altitude Group (ALT), InnovaDerma (IDP), Bonmarche (BON), and Jangada Mines (JAN). These companies are all part of the "pharmaceutical products" industry.
OptiBiotix Health vs. Its Competitors
CyanConnode (LON:CYAN) and OptiBiotix Health (LON:OPTI) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their community ranking, earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends, media sentiment and risk.
CyanConnode received 67 more outperform votes than OptiBiotix Health when rated by MarketBeat users. Likewise, 60.74% of users gave CyanConnode an outperform vote while only 59.18% of users gave OptiBiotix Health an outperform vote.
CyanConnode has a net margin of -20.45% compared to OptiBiotix Health's net margin of -524.43%. CyanConnode's return on equity of -28.94% beat OptiBiotix Health's return on equity.
OptiBiotix Health has lower revenue, but higher earnings than CyanConnode. CyanConnode is trading at a lower price-to-earnings ratio than OptiBiotix Health, indicating that it is currently the more affordable of the two stocks.
In the previous week, CyanConnode's average media sentiment score of 0.00 equaled OptiBiotix Health'saverage media sentiment score.
CyanConnode has a beta of 1.6, indicating that its stock price is 60% more volatile than the S&P 500. Comparatively, OptiBiotix Health has a beta of 1.71, indicating that its stock price is 71% more volatile than the S&P 500.
29.1% of CyanConnode shares are owned by institutional investors. Comparatively, 4.9% of OptiBiotix Health shares are owned by institutional investors. 17.8% of CyanConnode shares are owned by insiders. Comparatively, 12.0% of OptiBiotix Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
CyanConnode beats OptiBiotix Health on 9 of the 13 factors compared between the two stocks.
Get OptiBiotix Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for OPTI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding OPTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
OptiBiotix Health Competitors List
Related Companies and Tools
This page (LON:OPTI) was last updated on 6/12/2025 by MarketBeat.com Staff
Buy OPTI Stock Free OPTI Stock Alerts